OncoC4 begins phase 1/2 Alzheimer's trial dosing
April 10, 2026 | 09:16
The biotechnology company administered its ONC-841 candidate to the initial patient in early-to-mid-stage testing for the neurodegenerative disease.
Alamar Launches New Alzheimer's Biomarker Detection Assay
January 13, 2026 | 14:38
The biotechnology company introduces its blood-based testing solution for Alzheimer's disease research, offering researchers an advanced tool to detect multiple biomarkers simultaneously through the NULISAqpcr platform.
Alzheimer’s Association Issues First Guideline for Blood Biomarker Testing
July 30, 2025 | 09:00
A new era of early detection begins—paving the way for better brain health.
Lifestyle Changes Improve Brain Health, Says Alzheimer’s Association Study
July 29, 2025 | 11:00
A walk, a salad, and a social chat—simple routines show powerful cognitive results.
Opera on Alzheimer’s to debut in Philadelphia festival
March 21, 2018 | 13:00
An opera involving two characters with Alzheimer’s will premiere at Opera Philadelphia as part of the company’s latest festival of experimental fare.
Latest News
Mobile Version